Bio Techne Corp Stock Shares Outstanding

TECH Stock  USD 64.92  0.57  0.87%   
Bio Techne Corp fundamentals help investors to digest information that contributes to Bio Techne's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Techne's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Techne stock.
Short Long Term Debt TotalTotal Assets
The current Common Stock Shares Outstanding is estimated to decrease to about 169.2 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bio Techne Corp Company Shares Outstanding Analysis

Bio Techne's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Bio Techne Shares Outstanding

    
  158.09 M  
Most of Bio Techne's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Techne Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Bio Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Bio Techne is extremely important. It helps to project a fair market value of Bio Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Bio Techne's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bio Techne's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bio Techne's interrelated accounts and indicators.
0.980.760.980.980.910.90.870.510.9-0.460.80.810.760.980.920.140.940.720.69-0.030.780.220.90.77
0.980.650.990.980.820.930.860.390.82-0.460.850.70.730.940.90.290.960.610.68-0.070.670.240.890.83
0.760.650.680.730.920.440.560.750.89-0.420.470.940.550.840.79-0.350.640.780.560.10.90.220.670.46
0.980.990.680.960.860.930.820.50.86-0.410.80.740.730.950.870.180.910.660.6-0.020.70.240.850.76
0.980.980.730.960.860.870.820.450.84-0.550.860.750.670.960.950.240.960.670.66-0.030.720.280.880.84
0.910.820.920.860.860.710.770.720.98-0.420.560.970.740.950.86-0.250.780.880.630.070.930.130.790.53
0.90.930.440.930.870.710.830.310.69-0.220.750.590.710.810.720.310.860.550.64-0.050.590.180.820.71
0.870.860.560.820.820.770.830.240.78-0.330.570.620.870.840.850.160.90.610.8-0.130.6-0.070.860.55
0.510.390.750.50.450.720.310.240.74-0.180.110.80.360.60.41-0.610.250.740.090.340.760.320.330.08
0.90.820.890.860.840.980.690.780.74-0.450.510.930.770.950.85-0.270.760.850.560.080.880.070.760.48
-0.46-0.46-0.42-0.41-0.55-0.42-0.22-0.33-0.18-0.45-0.57-0.38-0.21-0.54-0.64-0.2-0.53-0.36-0.170.01-0.33-0.19-0.42-0.59
0.80.850.470.80.860.560.750.570.110.51-0.570.470.360.730.770.580.850.320.56-0.130.460.440.761.0
0.810.70.940.740.750.970.590.620.80.93-0.380.470.60.860.75-0.380.660.860.560.180.980.190.70.44
0.760.730.550.730.670.740.710.870.360.77-0.210.360.60.750.71-0.030.720.710.61-0.080.61-0.210.810.33
0.980.940.840.950.960.950.810.840.60.95-0.540.730.860.750.950.010.910.770.650.010.820.220.870.71
0.920.90.790.870.950.860.720.850.410.85-0.640.770.750.710.950.170.950.680.7-0.060.70.190.890.77
0.140.29-0.350.180.24-0.250.310.16-0.61-0.27-0.20.58-0.38-0.030.010.170.37-0.330.23-0.29-0.360.160.270.6
0.940.960.640.910.960.780.860.90.250.76-0.530.850.660.720.910.950.370.580.79-0.130.630.170.940.84
0.720.610.780.660.670.880.550.610.740.85-0.360.320.860.710.770.68-0.330.580.410.140.860.010.650.3
0.690.680.560.60.660.630.640.80.090.56-0.170.560.560.610.650.70.230.790.41-0.340.590.090.780.56
-0.03-0.070.1-0.02-0.030.07-0.05-0.130.340.080.01-0.130.18-0.080.01-0.06-0.29-0.130.14-0.340.180.030.01-0.13
0.780.670.90.70.720.930.590.60.760.88-0.330.460.980.610.820.7-0.360.630.860.590.180.210.710.44
0.220.240.220.240.280.130.18-0.070.320.07-0.190.440.19-0.210.220.190.160.170.010.090.030.210.120.45
0.90.890.670.850.880.790.820.860.330.76-0.420.760.70.810.870.890.270.940.650.780.010.710.120.74
0.770.830.460.760.840.530.710.550.080.48-0.591.00.440.330.710.770.60.840.30.56-0.130.440.450.74
Click cells to compare fundamentals

Bio Shares Outstanding Historical Pattern

Today, most investors in Bio Techne Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bio Techne's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Bio Techne shares outstanding as a starting point in their analysis.
   Bio Techne Shares Outstanding   
       Timeline  
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Bio Common Stock Shares Outstanding

Common Stock Shares Outstanding

169.2 Million

As of now, Bio Techne's Common Stock Shares Outstanding is increasing as compared to previous years.
Based on the latest financial disclosure, Bio Techne Corp has 158.09 M of shares currently outstending. This is 12.43% lower than that of the Life Sciences Tools & Services sector and 47.95% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 72.35% higher than that of the company.

Bio Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Techne's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Techne could also be used in its relative valuation, which is a method of valuing Bio Techne by comparing valuation metrics of similar companies.
158.1M279.9M190.8M188.7M100%
Bio Techne is currently under evaluation in shares outstanding category among its peers.

Bio Techne ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bio Techne's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bio Techne's managers, analysts, and investors.
54.8%
Environmental
Governance
Social

Bio Fundamentals

Return On Equity0.0783
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-30%-20%-10%0%10%20%30%
Return On Asset0.0568
Profit Margin0.13 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Operating Margin0.18 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Current Valuation10.49 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%
Shares Outstanding158.09 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110%20%30%40%
Shares Owned By Insiders1.45 %
Shares Owned By Institutions98.55 %
Number Of Shares Shorted3.95 M
Price To Earning74.38 X
Price To Book4.94 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%
Price To Sales8.58 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
Revenue1.16 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%12,000%
Gross Profit792 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%12,000%14,000%
EBITDA310.37 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110,000%20,000%30,000%40,000%50,000%60,000%
Net Income168.07 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110,000%20,000%30,000%40,000%50,000%60,000%70,000%
Cash And Equivalents247.03 M
Cash Per Share6.30 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%30,000%
Total Debt419.54 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3120,000%40,000%60,000%80,000%
Debt To Equity0.19 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-50%0%50%100%
Current Ratio3.44 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%500%
Book Value Per Share13.16 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110,000%20,000%30,000%40,000%50,000%
Cash Flow From Operations298.98 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%30,000%
Short Ratio4.22 X
Earnings Per Share0.98 X
Price To Earnings To Growth1.61 X
Target Price85.42
Number Of Employees3.1 K
Beta1.26
Market Capitalization10.26 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%
Total Asset2.7 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110,000%20,000%30,000%40,000%50,000%
Retained Earnings1.33 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150,000%100,000%150,000%
Working Capital458.04 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset253.89 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%12,000%14,000%
Current Liabilities54.15 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%
Annual Yield0 %
Five Year Return0.56 %
Net Asset2.7 B
Last Dividend Paid0.32

About Bio Techne Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bio Techne Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Techne using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.294
Dividend Share
0.32
Earnings Share
0.98
Revenue Per Share
7.568
Quarterly Revenue Growth
0.09
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.